INTERNATIONAL CONFERENCE ON ALZHEIMER'S DISEASE

AND RELATED DISORDERS IN THE MIDDLE EAST

5th Edition: Larnaka, Cyprus  •  May 15-17, 2009

 

General Info

2001 Edition

2003 Edition

2005 Edition

2007 Edition

Program

Speakers

Abstracts

Accommodations

Registration

Sponsorship/Exhibit

Supporters

Contact

CONVENERS

Robert P. Friedland, MD - 1st, 2nd, 3rd, 4th EDITIONS CONVENER - Dr Friedland is a clinical and research neurologist interested in behavior and aging. He is a graduate of the City College of New York and the Mount Sinai School of Medicine (1973). He completed his neurology residency at the Mount Sinai Hospital in New York and from 1977-1978 was a Fellow in dementia and aging under Dr. Robert Katzman at the Albert Einstein College of Medicine, NY. Since then he has worked at the University of California Davis and the Research Medicine Group of the Lawrence Berkeley Laboratory of the University California, Berkeley. He served from 1985 to 1990 as Deputy Clinical Director and Chief of the Section on Brain Aging and Dementia of the National Institute on Aging Institute, National Institutes of Health, Bethesda, MD. Since 1990 he has worked at Case Western Reserve University in the School of Medicine, where he is currently Professor of Neurology and Psychiatry and Chief of the Laboratory of Neurogeriatrics. Dr. Friedland’s work has focused on clinical and biological issues in Alzheimer’s disease and related disorders. He was among the first to document patterns of abnormal brain metabolism and cerebral blood flow in the disease using positron emission and single photon emission computed tomography. He also contributed early studies on the use of magnetic resonance imaging in dementia. The first studies of problems of driving behavior in patients with Alzheimer’s disease came from his group at the NIH. More recently, Dr. Friedland has been working on the patterns of disease occurrence and risk and protective factors, with studies of the Kikuku in Kenya, Jews and Arabs in Israel and Caucasian and African-American subjects in Cleveland. He has documented a series of important determinants of the disease, including physical and mental inactivity, smoking and diet. This work has focused on interactions of genetic and environmental lifestyle elements. His group is also using animal models to better define the pathophysiology of Alzheimer’s disease and develop new treatments.

Changiz Geula, PhD - 5th EDITION CONVENER - Dr. Geula is Professor of Neuroscience at the Cognitive Neurology and Alzheimer’s Disease Center, Northwestern University, Feinberg School of Medicine, Chicago, IL. He joined Northwestern in 2007 after two decades at Harvard Medical School, Boston, Massachusetts. Dr. Geula is the Director of the Laboratory for Cognitive and Molecular Morphometry at Northwestern University Medical School. Dr. Geula received his doctorate in Biopsychology/Neuroscience from Wayne State University, Detroit, Michigan. Dr. Geula’s research interests have focused on the aging of the brain and neurodegenerative disorders which afflict the elderly, particularly Alzheimer’s disease. One line of research pursued in his laboratory concentrates on age-related changes in the nervous system, including changes in amyloid levels and microglia function, which contribute to selective neuronal loss and dysfunction in Alzheimer’s disease.

Chris Messis, MD - CHAIR, LOCAL ORGANIZING COMMITTEE - Dr. Messis is Director Director Neuropsychiatry, YGIA Polyclinic in Limassol and Chairman of the Cyprus Mental Health Commission.  He obtained his medical degree from the Athens University in Greece and completed his residence in Neurology and then Psychiatry in Brooklyn, NY.  Dr. Messis has been the President of the Cyprus Neurological Society between 1981 and 1997 and is currently Cyprus' delegate to EFNS, WFN and the European Board of Neurology.  He had authored several books and papers published in peer-reviewed journals. 

Marwan Sabbagh, MD - 5th EDITION CONVENER - Dr. Sabbagh is the founding director of the Cleo Roberts Center for Clinical Research. Opened in 2000, the Center, with Dr. Sabbagh as the principle investigator, has conducted more than 30 clinical trials for Alzheimer's and Parkinson's diseases, as well as prostate cancer and arthritis. Dr. Sabbagh, a board-certified neurologist, received his medical degree from the University of Arizona. He is also the Associate Director of the Arizona Alzheimer's Disease Core Center, a clinical instructor in the Sun Health/St. Joseph's Hospitals Geriatric Fellowship Program, clinical assistant professor of neurosciences at the University of California-San Diego and a visiting scientist in the Department of Neurology at Mayo Clinic Scottsdale. Dr. Sabbagh served his residency in neurology at Baylor College of Medicine and a fellowship in geriatric neurology and dementia at the UC-SD School of Medicine.

TOP

 

CONVENERS and LOCAL ORGANIZING COMMITTEE

Fifth Edition Conveners:

Changiz Geula, PhD, Professor, Northwestern University

Marwan Sabbagh, MD, Director, Cleo Roberts Center of Clinical Research, Sun Health Research Institute


Chair, Local Organizing Committee:

Chris Messis, MD, Chairman, Mediterranean Neurological Society

 

World Events Forum, Inc. ©2001-2008